Medtech firm outlines objectives for wound care following government backing

Medical products and technologies company ConvaTec has welcomed the government’s support for the wound care industry as part of the Life Sciences Sector Deal, and has outlined its own objectives to supporting the government’s actions.

The company has been working with the Association of British HealthTech Industries, healthcare providers and UK academia to identify ways of improving patient outcomes and maximise financial efficiency in the wound care industry. This will include the use of new digital clinical decision support tools to try and support health professionals and patients.

Simon Whitfield, vice president & UK general manager of ConvaTec said: “We are proud to be contributing to the Wound Care Sector Deal, which brings key stakeholders across the NHS, government and industry together to reduce variation in wound assessments and deliver better outcomes for patients and healthcare professionals. Our investment demonstrates ConvaTec’s support for the deal and illustrates its commitment to improving outcomes and value for patients across the UK.”

ConvTec’s contribution is part of a £10 million investment over three years in R&D and academia, and the company will partner NHS health providers and universities to pilot projects aimed at improving patient care.

Una Adderley, National Wound Care Strategy Programme director, AHSN Network, said: “We are delighted that the Life Sciences Sector Deal 2 has included wound care as a focus. Industry and innovation are important in the emerging National Wound Care Strategy Programme and we welcome this opportunity for closer collaborative working to improve care for patients with wounds.”